Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-15

Clinical Trial Update: Randomized Trial of a Nutritional Supplement in Alzheimer's Disease [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports completion of a Phase 3 randomized trial evaluating a nutritional supplement in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nutritional supplement (unspecified)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED